J Mark Sloan (@jmarksloan) 's Twitter Profile
J Mark Sloan

@jmarksloan

Factotum hematologist but esp AL Amyloidosis, gene tx for HbSS, & HTLV associated ATLL. Assoc Prof and Heme/onc Program Director @The_BMC. The J is for jenius.

ID: 1578929666

linkhttp://www.bu.edu/amyloid/ calendar_today08-07-2013 23:49:14

1,1K Tweet

2,2K Followers

2,2K Following

J Mark Sloan (@jmarksloan) 's Twitter Profile Photo

Valemetostat, an EZH1/2 inhibitor approved in Japan for Adult T cell lymphoma/leukemia, has an ORR of 46% in R/R disease. Sadly Daiichi Sankyo US has NO valemetostat compassionate use program in the US. None. #ASH24 maya srinivasan HTLV Aware HTLV.net @StefanBartaMD

Valemetostat, an EZH1/2 inhibitor approved in Japan for Adult T cell lymphoma/leukemia, has an ORR of 46% in R/R disease. 

Sadly <a href="/DaiichiSankyoUS/">Daiichi Sankyo US</a> has NO valemetostat compassionate use program in the US.  None. 

 #ASH24   <a href="/mayadsrinivasan/">maya srinivasan</a> <a href="/HTLVaware/">HTLV Aware</a> <a href="/HTLVnet/">HTLV.net</a> @StefanBartaMD